Omega Diagnostics gets first US order for 'FoodPrint' system

By

Sharecast News | 06 Jan, 2023

Updated : 15:01

17:21 03/05/24

  • 3.95
  • 0.00%0.00
  • Max: 4.03
  • Min: 3.86
  • Volume: 127,670
  • MM 200 : 0.30

Omega Diagnostics announced on Friday that it had received a maiden purchase order for its ‘FoodPrint’ system from a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in the United States.

The AIM-traded firm also said it had appointed a new US importer for FoodPrint kits.

It said that, using a “small” finger prick of blood, the FoodPrint test could quickly identify an individual's unique food sensitivity reactions, allowing the patient to adjust and plan to a new diet and address IgG-mediated food sensitivities.

FoodPrint analyses up to 222 foods for IgG antibodies, with the company said it was trusted by more than 150 laboratories globally to help fast-track a guided elimination diet, allowing a “more focused and actionable result” for practitioners and their patients.

The board said it expected installation at the laboratory to start later in January, and after a period of validation and gaining necessary approvals, the processing of tests would begin later in the quarter.

As well as being CLIA-certified, the company said the laboratory receiving the system was also College of American Pathologists-accredited, and was specialised in providing functional tests for both consumers and healthcare practitioners.

Omega said it had also secured an importer for FoodPrint kits into the United States, which would import kits for the CLIA laboratory, as well as for Omega's own direct channels in future.

Although the value of the initial purchase order was around £50,000, the firm said the US market was a “key area of focus” for its growth strategy, with the installation set to be the first in the US market in more than seven years, representing the start of its planned expansion into the country.

“The US is the single largest market for food sensitivity testing globally, with an ever-increasing demand for personalised medicine, and is a focus area for our growth plans,” said chief executive officer Jag Grewal.

“This installation reflects a key milestone in our expansion plans, the receiving laboratory is ideally placed to commercialise FoodPrint in the US market as they are already providing a range of other functional tests.

“The appointment of the US importer will act as a foundation for our expansion into the region.”

At 1501 GMT, shares in Omega Diagnostics Group were down 0.65% at 3.83p.

Reporting by Josh White for Sharecast.com.

Last news